Albania vs Kyrgyzstan: Cause of death, by non-communicable diseases, male
Albania
59.3%
in 2021
Kyrgyzstan
59.5%
in 2021
Albania rank
97th
Kyrgyzstan rank
94th
Cause of death, by non-communicable diseases, male over time
- Albania
- Kyrgyzstan
How they compare
Kyrgyzstan currently reports 59.5% against 59.3% in Albania, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Albania ahead.
Albania ranks 97th and Kyrgyzstan ranks 94th of 185 countries.
Albania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Albania | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.1% | 66.3% | 14.8% | Albania |
| 2010s | 90.2% | 77.3% | 12.9% | Albania |
| 2020s | 67.5% | 61.4% | 6.1% | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Albania or Kyrgyzstan?
- Kyrgyzstan, at 59.5% against 59.3% in Albania as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Albania and Kyrgyzstan?
- 0.2%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Albania and Kyrgyzstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Albania and Kyrgyzstan rank globally for cause of death, by non-communicable diseases, male?
- Albania ranks 97th and Kyrgyzstan ranks 94th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.